edoc

Statistics Overview

All items > Item: Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3 : a phase II, multi-centre, double-blind, randomized, placebo-controlled trial
Downloads
Activity Overview
296Downloads
280Hits